Table 1. Patients and clinicopathologic factors.
Training set | Validation set | P* | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Factors | Nr0 (n = 701) | Nr1 (n = 441) | Nr2 (n = 484) | Nr3 (n = 477) | Total (n = 2103) | P | Nr0 (n = 157) | Nr1 (n = 115) | Nr2 (n = 109) | Nr3 (n = 91) | Total (n = 472) | P | |
Gender | 0.172 | 0.248 | 0.051 | ||||||||||
Male | 501 | 308 | 361 | 333 | 1503 | 103 | 75 | 71 | 67 | 316 | |||
Female | 200 | 133 | 123 | 144 | 600 | 54 | 40 | 38 | 24 | 156 | |||
Age (years) | 0.067 | 0.131 | 0.059 | ||||||||||
≥ 60 | 308 | 213 | 209 | 194 | 924 | 73 | 57 | 48 | 52 | 230 | |||
< 60 | 393 | 228 | 272 | 286 | 1179 | 84 | 58 | 61 | 39 | 242 | |||
Tumor location | 0.152 | 0.245 | 0.112 | ||||||||||
Upper third | 175 | 104 | 128 | 117 | 524 | 39 | 20 | 25 | 19 | 103 | |||
Middle third | 155 | 96 | 96 | 119 | 466 | 38 | 39 | 29 | 22 | 128 | |||
Lower third | 357 | 232 | 253 | 230 | 1072 | 77 | 55 | 53 | 46 | 231 | |||
≥ 2/3 stomach | 14 | 9 | 7 | 11 | 41 | 3 | 1 | 2 | 4 | 10 | |||
Macroscopic type | < 0.001 | < 0.001 | 0.069 | ||||||||||
Borrmann 0–II | 395 | 284 | 280 | 225 | 1184 | 85 | 83 | 59 | 17 | 244 | |||
Borrmann III– IV | 306 | 157 | 204 | 252 | 919 | 72 | 32 | 50 | 74 | 228 | |||
Tumor differentiation | < 0.001 | < 0.001 | 0.141 | ||||||||||
Well/Moderately | 138 | 124 | 96 | 56 | 414 | 30 | 25 | 16 | 8 | 79 | |||
Poorly | 563 | 317 | 388 | 421 | 1689 | 127 | 90 | 93 | 83 | 393 | |||
Lymphovascular invasion | 0.008 | 0.003 | 0.083 | ||||||||||
Negative | 437 | 292 | 305 | 275 | 1311 | 90 | 82 | 60 | 42 | 274 | |||
Positive | 264 | 147 | 179 | 202 | 792 | 67 | 33 | 49 | 49 | 198 | |||
Perineural invasion | 0.004 | < 0.001 | 0.054 | ||||||||||
Negative | 560 | 374 | 377 | 368 | 1679 | 121 | 91 | 69 | 67 | 358 | |||
Positive | 141 | 67 | 107 | 109 | 424 | 36 | 14 | 40 | 24 | 114 | |||
Adjuvant chemotherapy | 0.087 | 0.271 | 0.090 | ||||||||||
Present | 254 | 181 | 195 | 207 | 837 | 47 | 45 | 44 | 32 | 168 | |||
Absent/Unclear | 447 | 260 | 299 | 270 | 1266 | 110 | 70 | 65 | 59 | 304 | |||
Tumor size | < 0.001 | < 0.001 | 0.102 | ||||||||||
≤ 4.5 cm | 234 | 191 | 178 | 99 | 702 | 51 | 54 | 49 | 17 | 171 | |||
4.5-7.5 cm | 330 | 188 | 230 | 241 | 989 | 71 | 49 | 43 | 33 | 196 | |||
≥ 7.5 cm | 137 | 62 | 73 | 140 | 412 | 35 | 12 | 17 | 41 | 105 | |||
Retrieved lymph nodes | 0.901 | 0.900 | 0.121 | ||||||||||
≥ 15 | 499 | 323 | 348 | 342 | 1512 | 119 | 87 | 84 | 66 | 356 | |||
< 15 | 202 | 118 | 136 | 135 | 591 | 38 | 28 | 25 | 25 | 116 | |||
T Stage | < 0.001 | < 0.001 | 0.097 | ||||||||||
T1 | 42 | 52 | 27 | 6 | 127 | 13 | 17 | 3 | 6 | 39 | |||
T2 | 81 | 74 | 60 | 28 | 243 | 22 | 29 | 13 | 2 | 66 | |||
T3 | 57 | 54 | 41 | 19 | 171 | 10 | 7 | 7 | 6 | 30 | |||
T4a | 435 | 229 | 309 | 331 | 1304 | 91 | 57 | 79 | 63 | 290 | |||
T4b | 86 | 32 | 47 | 93 | 258 | 21 | 5 | 7 | 14 | 47 | |||
N Stage | < 0.001 | < 0.001 | 0.194 | ||||||||||
N0 | 701 | 0 | 0 | 0 | 701 | 157 | 0 | 0 | 0 | 157 | |||
N1 | 0 | 316 | 68 | 21 | 405 | 0 | 75 | 16 | 15 | 106 | |||
N2 | 0 | 119 | 216 | 84 | 419 | 0 | 26 | 46 | 3 | 75 | |||
N3a | 0 | 6 | 184 | 215 | 405 | 0 | 11 | 43 | 35 | 89 | |||
N3b | 0 | 0 | 16 | 157 | 173 | 0 | 3 | 4 | 38 | 45 | |||
TNM Stage | < 0.001 | < 0.001 | 0.066 | ||||||||||
IA | 290 | 0 | 0 | 0 | 290 | 51 | 0 | 0 | 0 | 51 | |||
IB | 129 | 50 | 11 | 2 | 192 | 35 | 10 | 7 | 2 | 54 | |||
IIA | 101 | 64 | 22 | 3 | 190 | 25 | 10 | 3 | 2 | 40 | |||
IIB | 92 | 47 | 36 | 12 | 187 | 25 | 9 | 8 | 4 | 46 | |||
IIIA | 82 | 171 | 79 | 37 | 369 | 20 | 66 | 6 | 11 | 103 | |||
IIIB | 7 | 92 | 167 | 75 | 341 | 1 | 17 | 48 | 12 | 78 | |||
IIIC | 0 | 17 | 169 | 348 | 534 | 0 | 3 | 37 | 60 | 100 |